Glucose tolerance and cardiovascular risk biomarkers in non-diabetic non-obese obstructive sleep apnea patients: Effects of long-term continuous positive airway pressure

Respiratory Medicine

Volumn 112, Issue , 2016, Pages 119-125

  Monneret, D ^a,b   Tamisier, R ^a,b   Ducros, V ^b   Faure, P ^a,b   Halimi, S ^b   Baguet, J P ^b   Levy P ^a,b   Pepin J L ^a,b   Borel, A L ^a,b  

^a UNIV GRENOBLE ALPES   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Biomarkers; Cardiovascular risk; Glucose tolerance; Long term CPAP; Obstructive sleep apnea; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HOMOCYSTEINE; INSULIN; PROINSULIN; CHOLESTEROL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN A1C PROTEIN, HUMAN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); TRIACYLGLYCEROL;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIET RESTRICTION; DISEASE SEVERITY; ELECTROCARDIOGRAM; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; ELECTROOCULOGRAM; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HEART FAILURE; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LABORATORY TEST; LONG TERM CARE; MALE; MIDDLE AGED; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; ARTERIAL WALL THICKNESS; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; COMPLICATION; ECHOGRAPHY; GLUCOSE TOLERANCE TEST; METABOLISM; RISK FACTOR; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME;

ADULT; BIOMARKERS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CONTINUOUS POSITIVE AIRWAY PRESSURE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HOMOCYSTEINE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; POLYSOMNOGRAPHY; PROINSULIN; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 84960113443     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2016.01.015     Document Type: Article

References (42)

1. J.P. Baguet, G. Barone-Rochette, R. Tamisier, P. Levy, and J.L. Pépin Mechanisms of cardiac dysfunction in obstructive sleep apnea Nat. Rev. Cardiol. 9 2012 679 688
2. L.F. Drager, S.M. Togeiro, V.Y. Polotsky, and G. Lorenzi-Filho Obstructive sleep apnea: A cardiometabolic risk in obesity and the metabolic syndrome J. Am. Coll. Cardiol. 62 2013 569 576
3. M.S. Ip, B. Lam, M.M. Ng, W.K. Lam, K.W. Tsang, and K.S. Lam Obstructive sleep apnea is independently associated with insulin resistance Am. J. Respir. Crit. Care Med. 165 2002 670 676
4. S. Pamidi, K. Wroblewski, J. Broussard, A. Day, E.C. Hanlon, V. Abraham, and E. Tasali Obstructive sleep apnea in young lean men: Impact on insulin sensitivity and secretion Diabetes Care 35 2012 2384 2389
5. I. Jullian-Desayes, M. Joyeux-Faure, R. Tamisier, S. Launois, A.L. Borel, P. Levy, and et al. Impact of obstructive sleep apnea treatment by continuous positive airway pressure on cardiometabolic biomarkers: A systematic review from sham CPAP randomized controlled trials Sleep. Med. Rev. 21 2015 23 38
6. C. Fava, S. Dorigoni, F. Dalle Vedove, E. Danese, M. Montagnana, G.C. Guidi, and et al. Effect of CPAP on blood pressure in patients with OSA/hypopnea a systematic review and meta-analysis Chest 145 2013 762 771
7. L. Hecht, R. Mohler, and G. Meyer Effects of CPAP-respiration on markers of glucose metabolism in patients with obstructive sleep apnoea syndrome: A systematic review and meta-analysis Ger. Med. Sci. 9 2011 Doc20
8. P. Steiropoulos, N. Papanas, E. Nena, E. Maltezos, and D. Bouros Continuous positive airway pressure treatment in patients with sleep apnoea: Does it really improve glucose metabolism? Curr. Diabetes Rev. 6 2010 156 166
9. Xu H, Yi H, Guan J, Yin S. Effect of continuous positive airway pressure on lipid profile in patients with obstructive sleep apnea syndrome: A meta-analysis of randomized controlled trials. Atherosclerosis;234:446-453.
10. M.T. Lin, H.H. Lin, P.L. Lee, P.H. Weng, C.C. Lee, T.C. Lai, and et al. Beneficial effect of continuous positive airway pressure on lipid profiles in obstructive sleep apnea: A meta-analysis Sleep. Breath. 19 2014 809 817
11. L. Lavie Oxidative stress-a unifying paradigm in obstructive sleep apnea and comorbidities Prog. Cardiovasc Dis. 51 2009 303 312
12. L. Lavie Oxidative stress inflammation and endothelial dysfunction in obstructive sleep apnea Front. Biosci. Elite Ed. 4 2011 1391 1403
13. A. Svatikova, R. Wolk, L.O. Lerman, L.A. Juncos, E.L. Greene, J.P. McConnell, and V.K. Somers Oxidative stress in obstructive sleep apnoea Eur. Heart J. 26 2005 2435 2439
14. G. Querejeta Roca, S. Redline, N. Punjabi, B. Claggett, C.M. Ballantyne, S.D. Solomon, and A.M. Shah Sleep apnea is associated with subclinical myocardial injury in the community. The ARIC-SHHS study Am. J. Respir. Crit. Care Med. 188 2013 1460 1465
15. M.T. Maeder, P. Ammann, H. Rickli, O.D. Schoch, W. Korte, C. Hurny, and et al. N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea Sleep. Breath. 12 2008 7 16
16. Colish J, Walker JR, Elmayergi N, Almutairi S, Alharbi F, Lytwyn M, et al. Obstructive sleep apnea: Effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI. Chest;141:674-681.
17. A.L. Borel, D. Monneret, R. Tamisier, J.P. Baguet, P. Faure, P. Levy, and et al. The severity of nocturnal hypoxia but not abdominal adiposity is associated with insulin resistance in non-obese men with sleep apnea PLoS One 8 2013 e71000
18. Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurement techniques in clinical research Rep. Am. Acad. Sleep Med. Task Force Sleep 22 1999 667 689
19. Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension J. Hypertens. 31 2013 1925 1938
20. D.M. Nathan, M.B. Davidson, R.A. DeFronzo, R.J. Heine, R.R. Henry, R. Pratley, and B. Zinman Impaired fasting glucose and impaired glucose tolerance: Implications for care Diabetes Care 30 2007 753 759
21. M. Matsuda, and R.A. DeFronzo Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp Diabetes Care 22 1999 1462 1470
22. A. Mari, G. Pacini, E. Murphy, B. Ludvik, and J.J. Nolan A model-based method for assessing insulin sensitivity from the oral glucose tolerance test Diabetes Care 24 2001 539 548
23. W.A. Gunzler, H. Kremers, and L. Flohe An improved coupled test procedure for glutathione peroxidase (EC 1-11-1-9-) in blood Z Klin. Chem. Klin. Biochem. 12 1974 444 448
24. V. Ducros, H. Belva-Besnet, B. Casetta, and A. Favier A robust liquid chromatography tandem mass spectrometry method for total plasma homocysteine determination in clinical practice Clin. Chem. Lab. Med. 44 2006 987 990
25. D. Yang, Z. Liu, and H. Yang The impact of effective continuous positive airway pressure on homeostasis model assessment insulin resistance in non-diabetic patients with moderate to severe obstructive sleep apnea Diabetes Metab. Res. Rev. 28 2012 499 504
26. D. Yang, Z. Liu, H. Yang, and Q. Luo Effects of continuous positive airway pressure on glycemic control and insulin resistance in patients with obstructive sleep apnea: A meta-analysis Sleep. Breath. 17 2012 33 38
27. I.H. Iftikhar, M.F. Khan, A. Das, and U.J. Magalang Meta-analysis: Continuous positive airway pressure improves insulin resistance in patients with sleep apnea without diabetes Ann. Am. Thorac. Soc. 10 2013 115 120
28. L. Lavie Oxidative stress in obstructive sleep apnea and intermittent hypoxia-revisited-the bad ugly and good: Implications to the heart and brain Sleep. Med. Rev. 20 2015 27 45
29. K. Katsoulis, T. Kontakiotis, D. Spanogiannis, E. Vlachogiannis, M. Kougioulis, S. Gerou, and E. Daskalopoulou Total antioxidant status in patients with obstructive sleep apnea without comorbidities: The role of the severity of the disease Sleep. Breath. 15 2011 861 866
30. M. Mancuso, E. Bonanni, A. LoGerfo, D. Orsucci, M. Maestri, L. Chico, and et al. Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome Sleep. Med. 13 2012 632 636
31. A. Barcelo, F. Barbe, M. de la Pena, M. Vila, G. Perez, J. Pierola, and et al. Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment Eur. Respir. J. 27 2006 756 760
32. E. Wysocka, S. Cofta, T. Piorunek, S. Dziegielewska-Gesiak, W. Bryl, and L. Torlinski Blood antioxidant status, dysglycemia and obstructive sleep apnea Adv. Exp. Med. Biol. 756 2012 121 129
33. V.K. Somers, D.P. White, R. Amin, W.T. Abraham, F. Costa, A. Culebras, and et al. Sleep apnea and cardiovascular disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing J. Am. Coll. Cardiol. 52 2008 686 717
34. C. Kragelund, B. Gronning, L. Kober, P. Hildebrandt, and R. Steffensen N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease N. Engl. J. Med. 352 2005 666 675
35. A.A. Patwardhan, M.G. Larson, D. Levy, E.J. Benjamin, E.P. Leip, M.J. Keyes, and et al. Obstructive sleep apnea and plasma natriuretic peptide levels in a community-based sample Sleep 29 2006 1301 1306
36. A. Splaver, G.A. Lamas, and C.H. Hennekens Homocysteine and cardiovascular disease: Biological mechanisms, observational epidemiology, and the need for randomized trials Am. Heart J. 148 2004 34 40
37. P.M. Ueland, H. Refsum, S.A. Beresford, and S.E. Vollset The controversy over homocysteine and cardiovascular risk Am. J. Clin. Nutr. 72 2000 324 332
38. W. Jordan, C. Berger, S. Cohrs, A. Rodenbeck, G. Mayer, P.D. Niedmann, and et al. CPAP-therapy effectively lowers serum homocysteine in obstructive sleep apnea syndrome J. Neural Transm. 111 2004 683 689
39. S. Ryan, G.M. Nolan, E. Hannigan, S. Cunningham, C. Taylor, and W.T. McNicholas Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity Thorax 62 2007 509 514
40. D. Monneret, R. Tamisier, V. Ducros, C. Garrel, P. Levy, J.P. Baguet, and et al. The impact of obstructive sleep apnea on homocysteine and carotid remodeling in metabolic syndrome Respir. Physiol. Neurobiol. 180 2012 298 304
41. X. Niu, X. Chen, Y. Xiao, J. Dong, R. Zhang, M. Lu, and W. Kong The differences in homocysteine level between obstructive sleep apnea patients and controls: A meta-analysis PLoS One 9 2014 e95794
42. X. Chen, X. Niu, Y. Xiao, J. Dong, R. Zhang, M. Lu, and W. Kong Effect of continuous positive airway pressure on homocysteine levels in patients with obstructive sleep apnea: A meta-analysis Sleep. Breath. 18 2014 687 694